share_log

Institutional Owners May Consider Drastic Measures as Bausch Health Companies Inc.'s (NYSE:BHC) Recent US$150m Drop Adds to Long-term Losses

Institutional Owners May Consider Drastic Measures as Bausch Health Companies Inc.'s (NYSE:BHC) Recent US$150m Drop Adds to Long-term Losses

Bausch Health Companies Inc.,機構所有者可能會考慮採取嚴厲措施。”s(紐約證券交易所代碼:BHC)最近的1.5億美元下跌增加了長期損失
Simply Wall St ·  05/26 20:46

Key Insights

關鍵見解

  • Institutions' substantial holdings in Bausch Health Companies implies that they have significant influence over the company's share price
  • The top 11 shareholders own 52% of the company
  • Ownership research along with analyst forecasts data help provide a good understanding of opportunities in a stock
  • 機構持有Bausch Health Companies的大量股權意味着它們對該公司的股價具有重大影響
  • 前11名股東擁有公司52%的股份
  • 所有權研究以及分析師預測數據有助於更好地了解股票的機會

If you want to know who really controls Bausch Health Companies Inc. (NYSE:BHC), then you'll have to look at the makeup of its share registry. With 64% stake, institutions possess the maximum shares in the company. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).

如果你想知道誰真正控制了Bausch Health Companies Inc.(紐約證券交易所代碼:BHC),那麼你必須看看其股票登記處的構成。機構擁有64%的股份,是公司的最大股份。也就是說,如果股票上漲,該集團將受益最大(如果股價下跌,則損失最大)。

And institutional investors endured the highest losses after the company's share price fell by 6.1% last week. This set of investors may especially be concerned about the current loss, which adds to a one-year loss of 22% for shareholders. Also referred to as "smart money", institutions have a lot of sway over how a stock's price moves. Hence, if weakness in Bausch Health Companies' share price continues, institutional investors may feel compelled to sell the stock, which might not be ideal for individual investors.

在上週公司股價下跌6.1%之後,機構投資者遭受的損失最大。這組投資者可能特別擔心當前的虧損,這使股東一年的虧損增加了22%。也被稱爲 “智能貨幣”,機構對股票價格的走勢有很大的影響力。因此,如果Bausch Health Companies的股價持續疲軟,機構投資者可能會感到不得不出售該股票,這對於個人投資者來說可能並不理想。

Let's take a closer look to see what the different types of shareholders can tell us about Bausch Health Companies.

讓我們仔細看看不同類型的股東能告訴我們有關Bausch Health Companies的哪些信息。

ownership-breakdown
NYSE:BHC Ownership Breakdown May 26th 2024
紐約證券交易所:BHC 所有權明細 2024 年 5 月 26 日

What Does The Institutional Ownership Tell Us About Bausch Health Companies?

關於Bausch Health Companies,機構所有權告訴我們什麼?

Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.

機構投資者通常將自己的回報與常見指數的回報進行比較。因此,他們通常會考慮收購相關基準指數中包含的大型公司。

Bausch Health Companies already has institutions on the share registry. Indeed, they own a respectable stake in the company. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Bausch Health Companies, (below). Of course, keep in mind that there are other factors to consider, too.

Bausch Health Companies已經在股票登記處設立了機構。事實上,他們擁有該公司可觀的股份。這表明專業投資者有一定的信譽。但是我們不能僅僅依靠這個事實,因爲機構有時會像所有人一樣進行不良投資。如果兩個大型機構投資者試圖同時拋售股票,股價大幅下跌的情況並不少見。因此,值得查看Bausch Health Companies過去的收益軌跡(見下文)。當然,請記住,還有其他因素需要考慮。

earnings-and-revenue-growth
NYSE:BHC Earnings and Revenue Growth May 26th 2024
紐約證券交易所:BHC 收益和收入增長 2024 年 5 月 26 日

Since institutional investors own more than half the issued stock, the board will likely have to pay attention to their preferences. Our data indicates that hedge funds own 15% of Bausch Health Companies. That worth noting, since hedge funds are often quite active investors, who may try to influence management. Many want to see value creation (and a higher share price) in the short term or medium term. Looking at our data, we can see that the largest shareholder is Icahn Capital LP with 9.5% of shares outstanding. In comparison, the second and third largest shareholders hold about 7.5% and 7.2% of the stock.

由於機構投資者擁有已發行股票的一半以上,董事會可能必須注意他們的偏好。我們的數據顯示,對沖基金擁有Bausch Health Companies15%的股份。這值得注意,因爲對沖基金通常是非常活躍的投資者,他們可能會試圖影響管理層。許多人希望在短期或中期內看到價值創造(以及更高的股價)。從我們的數據來看,我們可以看到最大的股東是伊坎資本有限責任公司,其已發行股份佔9.5%。相比之下,第二和第三大股東持有約7.5%和7.2%的股份。

Looking at the shareholder registry, we can see that 52% of the ownership is controlled by the top 11 shareholders, meaning that no single shareholder has a majority interest in the ownership.

查看股東登記處,我們可以看到52%的所有權由前11名股東控制,這意味着沒有一個股東在所有權中擁有多數權益。

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. Quite a few analysts cover the stock, so you could look into forecast growth quite easily.

雖然研究公司的機構所有權可以爲您的研究增加價值,但研究分析師的建議以更深入地了解股票的預期表現也是一種好做法。有不少分析師報道了該股,因此你可以很容易地研究預測的增長。

Insider Ownership Of Bausch Health Companies

Bausch Health 公司的內部所有權

The definition of an insider can differ slightly between different countries, but members of the board of directors always count. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves.

不同國家對內部人士的定義可能略有不同,但董事會成員總是計算在內。公司管理層對董事會的回答,董事會應代表股東的利益。值得注意的是,有時高層管理人員自己也在董事會中。

Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.

當內部所有權表明領導層像公司的真正所有者一樣思考時,內部所有權是積極的。但是,高度的內部所有權也可以賦予公司內部的一小部分人巨大的權力。在某些情況下,這可能是負面的。

We can report that insiders do own shares in Bausch Health Companies Inc.. It is a pretty big company, so it is generally a positive to see some potentially meaningful alignment. In this case, they own around US$36m worth of shares (at current prices). Most would say this shows alignment of interests between shareholders and the board. Still, it might be worth checking if those insiders have been selling.

我們可以報告說,內部人士確實擁有Bausch Health Companies Inc.的股份。這是一家相當大的公司,因此看到一些潛在的有意義的調整通常是積極的。在這種情況下,他們擁有價值約3600萬美元的股票(按當前價格計算)。大多數人會說,這表明股東和董事會之間的利益一致。儘管如此,可能值得檢查一下這些內部人士是否一直在出售。

General Public Ownership

一般公有制

The general public-- including retail investors -- own 20% stake in the company, and hence can't easily be ignored. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.

包括散戶投資者在內的公衆擁有該公司20%的股份,因此不容忽視。這種所有權規模雖然可觀,但如果決策與其他大股東不同步,可能不足以改變公司政策。

Next Steps:

後續步驟:

It's always worth thinking about the different groups who own shares in a company. But to understand Bausch Health Companies better, we need to consider many other factors. Take risks for example - Bausch Health Companies has 1 warning sign we think you should be aware of.

擁有公司股份的不同群體總是值得考慮的。但是,爲了更好地了解Bausch Health Companies,我們需要考慮許多其他因素。以風險爲例——Bausch Health Companies有1個我們認爲你應該注意的警告信號。

But ultimately it is the future, not the past, that will determine how well the owners of this business will do. Therefore we think it advisable to take a look at this free report showing whether analysts are predicting a brighter future.

但歸根結底,決定這家企業所有者的表現的是未來,而不是過去。因此,我們認爲最好看一下這份免費報告,該報告顯示了分析師是否預測了更光明的未來。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注意:本文中的數字是使用過去十二個月的數據計算得出的,這些數據是指截至財務報表日期當月最後一天的12個月期間。這可能與全年年度報告數據不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論